StockData
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$16.02−0.68 (-4.07%)

Close on Nov 17, 2026Market cap $2.99BP/E –Yield –

Dyne Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Dyne Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 0.7× to 19.1×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.2×+0.2
2025Dec 31, 20254.0×+0.6
2024Dec 31, 20243.4×−2.0
2023Dec 29, 20235.4×+3.0
2022Dec 30, 20222.4×+0.9
2021Dec 31, 20211.5×−1.1
2020Dec 31, 20202.6×–

More Dyne Therapeutics figures

See a number that looks wrong?